{"success":true,"data":{"pressRelease":{"id":"19411","rtpr_id":"nNFC3HV0mL","ticker":"MEDP","exchange":"NASDAQ","all_tickers":["MEDP"],"title":"Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm","author":"Newsfile Corp","published_at":"2026-05-04T16:00:23.242Z","article_body":"New York, New York--(Newsfile Corp. - May 4, 2026) - Bronstein, Gewirtz &\nGrossman, LLC, a nationally recognized investor-rights law firm, announces\nthat a class action lawsuit has been filed against Medpace Holdings, Inc.\n(NASDAQ: MEDP) and certain of its officers.\n\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Medpace securities between April\n22, 2025 and February 9, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/MEDP (https://api.newsfilecorp.com/redirect/qpgPPiKBRj).\n\nMedpace Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1. Medpace's public statements regarding its expected book-to-bill ratio for\nthe fourth quarter and second half of fiscal year 2025 lacked a reasonable\nbasis;\n2. Defendants repeatedly portrayed an overly optimistic book-to-bill ratio of\napproximately 1.15 during earnings calls and other public communications,\ndespite contrary internal information; and\n3. as a result, Defendants' statements about the Company's business,\noperations, and financial prospects were materially false and misleading at\nall relevant times.\nWhat's Next for Medpace Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/MEDP\n(https://api.newsfilecorp.com/redirect/nog77UMWe5), or you may contact Peretz\nBronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein,\nGewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Medpace you\nhave until June 5, 2026, to request that the Court appoint you as lead\nplaintiff. Your ability to share in any recovery doesn't require that you\nserve as lead plaintiff.\n\nNo Cost to Medpace Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Medpace Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://api.newsfilecorp.com/redirect/EZ3GGHjrYL), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://api.newsfilecorp.com/redirect/xE044SKZ83), X\n(https://api.newsfilecorp.com/redirect/7n533hM5kQ), Facebook\n(https://api.newsfilecorp.com/redirect/ejgJJHMmvA), or Instagram\n(https://api.newsfilecorp.com/redirect/87LRRIO8j8).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 | info@bgandg.com\n\nAttorney advertising.\nPrior results do not guarantee similar outcomes.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/294767","article_body_html":"","raw_payload":{"data":{"id":"nNFC3HV0mL","title":"Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm","author":"Newsfile Corp","ticker":"MEDP","created":"2026-05-04T16:00:23.242Z","tickers":["MEDP"],"exchange":"NASDAQ","article_body":"New York, New York--(Newsfile Corp. - May 4, 2026) - Bronstein, Gewirtz &\nGrossman, LLC, a nationally recognized investor-rights law firm, announces\nthat a class action lawsuit has been filed against Medpace Holdings, Inc.\n(NASDAQ: MEDP) and certain of its officers.\n\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Medpace securities between April\n22, 2025 and February 9, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/MEDP (https://api.newsfilecorp.com/redirect/qpgPPiKBRj).\n\nMedpace Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1. Medpace's public statements regarding its expected book-to-bill ratio for\nthe fourth quarter and second half of fiscal year 2025 lacked a reasonable\nbasis;\n2. Defendants repeatedly portrayed an overly optimistic book-to-bill ratio of\napproximately 1.15 during earnings calls and other public communications,\ndespite contrary internal information; and\n3. as a result, Defendants' statements about the Company's business,\noperations, and financial prospects were materially false and misleading at\nall relevant times.\nWhat's Next for Medpace Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/MEDP\n(https://api.newsfilecorp.com/redirect/nog77UMWe5), or you may contact Peretz\nBronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein,\nGewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Medpace you\nhave until June 5, 2026, to request that the Court appoint you as lead\nplaintiff. Your ability to share in any recovery doesn't require that you\nserve as lead plaintiff.\n\nNo Cost to Medpace Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Medpace Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://api.newsfilecorp.com/redirect/EZ3GGHjrYL), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://api.newsfilecorp.com/redirect/xE044SKZ83), X\n(https://api.newsfilecorp.com/redirect/7n533hM5kQ), Facebook\n(https://api.newsfilecorp.com/redirect/ejgJJHMmvA), or Instagram\n(https://api.newsfilecorp.com/redirect/87LRRIO8j8).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 | info@bgandg.com\n\nAttorney advertising.\nPrior results do not guarantee similar outcomes.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/294767"},"type":"article","timestamp":"2026-05-04T16:00:23.284487343Z","server_sent_at_ms":1777910423284},"received_at":"2026-05-04T16:00:23.343Z","source_url":"https://www.newsfilecorp.com/release/294767"},"analysis":{"id":"14154","press_release_id":"19411","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman LLC announced that a class action lawsuit has been filed against Medpace Holdings, Inc. on behalf of investors who purchased securities between April 22, 2025 and February 9, 2026.\n\nThe complaint alleges that Medpace made materially false statements regarding its expected book-to-bill ratio and business prospects throughout the Class Period.\n\nInvestors suffering losses have until June 5, 2026, to request lead plaintiff appointment; representation is on a contingency fee basis with no cost to investors.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Medpace Holdings, Inc.","ticker":"MEDP","relationship":"target"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder regarding alleged securities violations."},"tickerRelevance":{"others":[],"primary":"MEDP"},"globalImportance":15,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman LLC announced that a class action lawsuit has been filed against Medpace Holdings, Inc. on behalf of investors who purchased securities between April 22, 2025 and February 9, 2026.\n\nThe complaint alleges that Medpace made materially false statements regarding its expected book-to-bill ratio and business prospects throughout the Class Period.\n\nInvestors suffering losses have until June 5, 2026, to request lead plaintiff appointment; representation is on a contingency fee basis with no cost to investors.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Medpace Holdings, Inc.","ticker":"MEDP","relationship":"target"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:a2703c5a1b5285fe","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-05-04T18:44:22.639Z","global_importance":15,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":41806,"modelName":"glm-4.7"}}